| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $38K | -71.4% |
| R&D Expense | $15.5M | +53.8% |
| SG&A Expense | $5.5M | +21.8% |
| Operating Income | -$20.9M | -45.0% |
| Interest Expense | $31K | +102.5% |
| Pre-tax Income | -$20.7M | -44.6% |
| Net Income | -$20.7M | -44.6% |
| EPS (Basic) | -$9.18 | -29.1% |
| EPS (Diluted) | -$9.18 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.5M | -69.5% |
| Current Assets | $3.9M | -72.9% |
| Total Assets | $5.0M | -66.3% |
| Current Liabilities | $1.8M | +12.6% |
| Stockholders' Equity | $3.2M | -75.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.3M | +52.1% |
| Capital Expenditures | $128K | +0.0% |
| Investing Cash Flow | -$936K | -710.5% |
| Financing Cash Flow | $284K | +157.4% |
| Free Cash Flow | -$7.4M | +51.7% |
| -29.1% |